R J BIO-TECH | MANGALAM GLOBAL ENTERPRISE | R J BIO-TECH/ MANGALAM GLOBAL ENTERPRISE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | 20.0 | - | View Chart |
P/BV | x | - | 2.9 | - | View Chart |
Dividend Yield | % | 0.0 | 0.1 | - |
R J BIO-TECH MANGALAM GLOBAL ENTERPRISE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
R J BIO-TECH Mar-22 |
MANGALAM GLOBAL ENTERPRISE Mar-23 |
R J BIO-TECH/ MANGALAM GLOBAL ENTERPRISE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 12 | 52 | 22.8% | |
Low | Rs | 5 | 29 | 17.8% | |
Sales per share (Unadj.) | Rs | 14.7 | 102.7 | 14.3% | |
Earnings per share (Unadj.) | Rs | -4.3 | 0.9 | -466.6% | |
Cash flow per share (Unadj.) | Rs | -4.2 | 1.1 | -368.3% | |
Dividends per share (Unadj.) | Rs | 0 | 0.02 | 0.0% | |
Avg Dividend yield | % | 0 | 0 | 0.0% | |
Book value per share (Unadj.) | Rs | -53.2 | 8.2 | -652.1% | |
Shares outstanding (eoy) | m | 9.47 | 138.56 | 6.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 0.4 | 147.1% | |
Avg P/E ratio | x | -2.0 | 44.3 | -4.5% | |
P/CF ratio (eoy) | x | -2.0 | 35.6 | -5.7% | |
Price / Book Value ratio | x | -0.2 | 5.0 | -3.2% | |
Dividend payout | % | 0 | 2.2 | -0.0% | |
Avg Mkt Cap | Rs m | 81 | 5,625 | 1.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 6 | 74 | 8.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 139 | 14,233 | 1.0% | |
Other income | Rs m | 7 | 52 | 12.9% | |
Total revenues | Rs m | 146 | 14,286 | 1.0% | |
Gross profit | Rs m | 12 | 286 | 4.1% | |
Depreciation | Rs m | 1 | 31 | 2.1% | |
Interest | Rs m | 58 | 147 | 39.6% | |
Profit before tax | Rs m | -40 | 161 | -25.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 34 | 0.0% | |
Profit after tax | Rs m | -40 | 127 | -31.9% | |
Gross profit margin | % | 8.4 | 2.0 | 416.8% | |
Effective tax rate | % | 0 | 21.0 | -0.0% | |
Net profit margin | % | -29.1 | 0.9 | -3,266.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 3 | 3,414 | 0.1% | |
Current liabilities | Rs m | 484 | 2,937 | 16.5% | |
Net working cap to sales | % | -345.9 | 3.4 | -10,318.6% | |
Current ratio | x | 0 | 1.2 | 0.5% | |
Inventory Days | Days | 3 | 1 | 177.0% | |
Debtors Days | Days | 7,265,677 | 538 | 1,351,133.6% | |
Net fixed assets | Rs m | 16 | 806 | 2.0% | |
Share capital | Rs m | 95 | 277 | 34.2% | |
"Free" reserves | Rs m | -598 | 852 | -70.2% | |
Net worth | Rs m | -503 | 1,130 | -44.6% | |
Long term debt | Rs m | 33 | 163 | 20.3% | |
Total assets | Rs m | 19 | 4,219 | 0.5% | |
Interest coverage | x | 0.3 | 2.1 | 14.5% | |
Debt to equity ratio | x | -0.1 | 0.1 | -45.6% | |
Sales to assets ratio | x | 7.2 | 3.4 | 214.7% | |
Return on assets | % | 92.4 | 6.5 | 1,422.8% | |
Return on equity | % | 8.0 | 11.2 | 71.6% | |
Return on capital | % | -3.8 | 23.8 | -15.8% | |
Exports to sales | % | 0 | 8.9 | 0.0% | |
Imports to sales | % | 2.5 | 0 | - | |
Exports (fob) | Rs m | NA | 1,267 | 0.0% | |
Imports (cif) | Rs m | 4 | NA | - | |
Fx inflow | Rs m | 0 | 1,267 | 0.0% | |
Fx outflow | Rs m | 4 | 12 | 29.3% | |
Net fx | Rs m | -4 | 1,255 | -0.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -47 | -672 | 7.0% | |
From Investments | Rs m | NA | -411 | -0.0% | |
From Financial Activity | Rs m | 47 | 1,091 | 4.3% | |
Net Cashflow | Rs m | 0 | 8 | -4.9% |
Indian Promoters | % | 60.3 | 75.0 | 80.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 39.7 | 25.0 | 158.7% | |
Shareholders | 245 | 15,712 | 1.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare R J BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | R J BIO-TECH | MANGALAM GLOBAL ENTERPRISE | S&P BSE FMCG |
---|---|---|---|
1-Day | 0.59% | -3.87% | 0.01% |
1-Month | 1.48% | 13.16% | 1.42% |
1-Year | -26.39% | 35.45% | 13.97% |
3-Year CAGR | -24.59% | 34.33% | 15.82% |
5-Year CAGR | -25.99% | -15.38% | 10.78% |
* Compound Annual Growth Rate
Here are more details on the R J BIO-TECH share price and the MANGALAM GLOBAL ENTERPRISE share price.
Moving on to shareholding structures...
The promoters of R J BIO-TECH hold a 60.3% stake in the company. In case of MANGALAM GLOBAL ENTERPRISE the stake stands at 75.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of R J BIO-TECH and the shareholding pattern of MANGALAM GLOBAL ENTERPRISE.
Finally, a word on dividends...
In the most recent financial year, R J BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
MANGALAM GLOBAL ENTERPRISE paid Rs 0.0, and its dividend payout ratio stood at 2.2%.
You may visit here to review the dividend history of R J BIO-TECH, and the dividend history of MANGALAM GLOBAL ENTERPRISE.
For a sector overview, read our fmcg sector report.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.